| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.72B | 5.43B | 4.73B | 4.20B | 3.37B |
| Gross Profit | 4.59B | 4.34B | 3.80B | 3.31B | 2.55B |
| EBITDA | 1.58B | 2.01B | 1.73B | 1.42B | 1.09B |
| Net Income | 851.94M | 838.91M | 671.03M | 465.19M | 294.25M |
Balance Sheet | |||||
| Total Assets | 11.01B | 8.55B | 7.62B | 7.38B | 6.96B |
| Cash, Cash Equivalents and Short-Term Investments | 1.26B | 1.01B | 689.52M | 1.09B | 981.79M |
| Total Debt | 4.82B | 2.79B | 2.60B | 2.67B | 2.79B |
| Total Liabilities | 6.35B | 4.13B | 3.74B | 3.88B | 3.83B |
| Stockholders Equity | 4.64B | 4.40B | 3.85B | 3.48B | 3.11B |
Cash Flow | |||||
| Free Cash Flow | 1.00B | 1.19B | 395.61M | 882.20M | 923.90M |
| Operating Cash Flow | 1.59B | 1.65B | 1.16B | 1.12B | 1.14B |
| Investing Cash Flow | -1.75B | -462.45M | -759.19M | -250.21M | -137.26M |
| Financing Cash Flow | 432.67M | -875.47M | -775.73M | -787.38M | -494.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$106.50B | 13.41 | 19.21% | 3.17% | 9.95% | 6.26% | |
73 Outperform | HK$13.62B | 10.61 | 9.57% | 4.43% | 10.89% | 2.02% | |
72 Outperform | HK$2.44B | 9.85 | 5.92% | 7.71% | 3.51% | 27.91% | |
68 Neutral | HK$127.26B | 13.95 | 23.29% | 4.21% | 5.29% | 53.87% | |
67 Neutral | HK$7.47B | 4.62 | 12.17% | 4.60% | 6.00% | 114.75% | |
65 Neutral | HK$7.63B | 8.27 | 16.18% | 1.70% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |